Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
celecoxib (celebrex) (1 trial)
glufosfamide (1 trial)
octreotide (sandostatin) (1 trial)
vatalanib (1 trial)
Carcinoma, Ovarian Epithelial (Phase 2)
Ovarian Neoplasms (Phase 2)
Squamous Intraepithelial Lesions of the Cervix (Phase 2)
Trials (2 total)
Trial APIs (4 total)